These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22911171)

  • 1. Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C.
    Kondo R; Yano H; Nakashima O; Tanikawa K; Nomura Y; Kage M
    J Gastroenterol; 2013 Apr; 48(4):526-34. PubMed ID: 22911171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly.
    Tejima K; Masuzaki R; Ikeda H; Yoshida H; Tateishi R; Sugioka Y; Kume Y; Okano T; Iwai T; Gotoh H; Katoh S; Suzuki A; Koike Y; Yatomi Y; Omata M; Koike K
    J Gastroenterol; 2010 Aug; 45(8):876-84. PubMed ID: 20339877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.
    Tseng PL; Wang JH; Hung CH; Tung HD; Chen TM; Huang WS; Liu SL; Hu TH; Lee CM; Lu SN
    Kaohsiung J Med Sci; 2013 Jul; 29(7):385-95. PubMed ID: 23768703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
    Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma.
    El-Bassiouni NE; Nosseir MM; Madkour ME; Zoheiry MM; Bekheit IW; Ibrahim RA; Ibrahim IM; El Bassiouny AE
    Mol Biol Rep; 2012 Jun; 39(6):6843-50. PubMed ID: 22318548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Link Between Platelet Numbers and Vascular Homeostasis Across Early and Late Stages of Fibrosis in Hepatitis C.
    Ali RO; Moon MS; Townsend EC; Hill K; Zhang GY; Bradshaw A; Guan H; Hamilton D; Kleiner DE; Auh S; Koh C; Heller T
    Dig Dis Sci; 2020 Feb; 65(2):524-533. PubMed ID: 31407130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis.
    Tamai H; Mori Y; Shingaki N; Shimizu R; Nuta J; Moribata K; Maeda Y; Muraki Y; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Takifuji K; Yamaue H; Ichinose M
    Hepatol Int; 2015 Jan; 9(1):67-75. PubMed ID: 25788381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.
    Afdhal NH; Dusheiko GM; Giannini EG; Chen PJ; Han KH; Mohsin A; Rodriguez-Torres M; Rugina S; Bakulin I; Lawitz E; Shiffman ML; Tayyab GU; Poordad F; Kamel YM; Brainsky A; Geib J; Vasey SY; Patwardhan R; Campbell FM; Theodore D
    Gastroenterology; 2014 Feb; 146(2):442-52.e1. PubMed ID: 24126097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.
    Shirabe K; Bekki Y; Gantumur D; Araki K; Ishii N; Kuno A; Narimatsu H; Mizokami M
    J Gastroenterol; 2018 Jul; 53(7):819-826. PubMed ID: 29318378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-mediated thrombocytopenia in Hepatitis C infection: The impact on fibrosis scores.
    Anugwom C; Ashraf A; Debes JD
    Dig Liver Dis; 2020 Jul; 52(7):797-798. PubMed ID: 32446728
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis.
    Khatun M; Ray RB
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients.
    Li X; Xu H; Gao P
    Med Sci Monit; 2019 Sep; 25():7243-7250. PubMed ID: 31558693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
    Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
    J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of thrombocytopenia in chronic hepatitis C viral infection.
    Osada M; Kaneko M; Sakamoto M; Endoh M; Takigawa K; Suzuki-Inoue K; Inoue O; Satoh K; Enomoto N; Yatomi Y; Ozaki Y
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):272-80. PubMed ID: 22327815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation in patients with chronic hepatitis C.
    Fusegawa H; Shiraishi K; Ogasawara F; Shimizu M; Haruki Y; Miyachi H; Matsuzaki S; Ando Y
    Tokai J Exp Clin Med; 2002 Dec; 27(4):101-6. PubMed ID: 12713014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
    Yoshida S; Ikenaga N; Liu SB; Peng ZW; Chung J; Sverdlov DY; Miyamoto M; Kim YO; Ogawa S; Arch RH; Schuppan D; Popov Y
    Gastroenterology; 2014 Dec; 147(6):1378-92. PubMed ID: 25173753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic stellate cells secreting WFA
    Bekki Y; Yoshizumi T; Shimoda S; Itoh S; Harimoto N; Ikegami T; Kuno A; Narimatsu H; Shirabe K; Maehara Y
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1387-1393. PubMed ID: 28008658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.